TOTAL: $55.26M
Year to Date: $84.16M
Company
(Symbol)#*		 Partner
(Country)		 Amt.
(M)		 Triggering
Event		 Details (Date)
Acorda
Therapeutics
Inc. (ACOR)		 Paul Capital Healthcare $5 Milestone payment Acorda received the payment as part of its agreement with an affiliate of Paul Capital to fund the expansion of its Zanaflex capsules sales force from 32 to 65 representatives; the payment was made upon the achievement of sales goals for 2006 (2/7)
Affymax Inc.
(AFFY)		 Takeda Pharmaceutical Co. (Japan) $10 Milestone payment Affymax received $10M as part of its exclusive global agreement with Takeda to develop and commercialize Hematide; the payment follows the completion of Phase I testing in Japan (2/1)
Avalon
Pharmaceuticals
Inc. (AVRX)		 Novartis AG (Switzerland) $0.5 Payment Avalon began the preliminary screening phase under a drug discovery collaboration, triggering the payment (2/26)
Medivir AB
(Sweden; SSE:
MVIRB)		 Tibotec Pharmaceuticals Ltd. (Belgium) €2.5
(US$3.26)		 Milestone payment Triggered by the start of a Phase I trial with an NS3/4A protease inhibitor to treat chronic hepatitis C virus infection (2/8)
Noven
Pharmaceuticals
Inc. (NOVN)		 Shire plc (UK) $25 Milestone payment Noven received the first of three possible $25M payments related to sales of Daytrana (2/21)
Pharmacopeia
Drug Discovery
Inc. (PCOP)		 Biovitrum (Sweden) $1 Milestone payment Pharmacopeia received $1M for delivery of an advanced lead to a program in diabetes (2/22)
Pharmasset Inc.* Roche (Switzerland) $5 Milestone payment Triggered by the start of a Phase I trial of R7128 for hepatitis C virus (2/28)
Unigene
Laboratories
Inc. (OTC BB:
UGNE)		 Novartis Pharma AG (Switzerland) $5.5 Milestone payment Unigene received the milestone payment for starting a Phase III study for osteoporosis (2/27)
Notes:
# Unless otherwise indicated, shares are traded on the Nasdaq exchange.
Currency conversions are based on exchange rates at the time of the deal.
ND = Not disclosed.
OTC BB = Over-the-Counter Bulletin Board; SSE = Stockholm Stock Exchange